HRT Financial’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$572K Buy
+23,624
New +$572K ﹤0.01% 2546
2026
Q1
– Sell
-38,296
Closed -$929K – 4209
2025
Q4
$929K Buy
38,296
+25,453
+198% +$618K ﹤0.01% 1769
2025
Q3
$312K Sell
12,843
-1,712
-12% -$41.5K ﹤0.01% 2144
2025
Q2
$353K Buy
+14,555
New +$351K ﹤0.01% 1773
2024
Q4
– Sell
-10,725
Closed -$261K – 2771
2024
Q3
$261K Buy
+10,725
New +$258K ﹤0.01% 1865

Other funds holding IBDS

HRT Financial's IBDS Position: Q2 2026 in Review

HRT Financial opened a new position in iShares iBonds Dec 2027 Term Corporate ETF (IBDS) in Q2 2026: 23,624 shares worth $572K. The stake represents ﹤0.01% of the portfolio and ranks #2546 among its holdings. This is a return to the name: HRT Financial previously reported a position in IBDS as recently as Q4 2025.

HRT Financial first reported a position in IBDS in Q3 2024 and has held it in 5 quarters since. The position peaked at $929K in Q4 2025. 416 funds tracked by Wall St. Rank hold IBDS as of Q2 2026.

  • HRT Financial held 23,624 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $572K as of Q2 2026.
  • iShares iBonds Dec 2027 Term Corporate ETF was a new HRT Financial position in Q2 2026.
  • iShares iBonds Dec 2027 Term Corporate ETF made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #2546 holding.
  • HRT Financial first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q3 2024 and has held it in 5 quarters since.
  • HRT Financial's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $929K in Q4 2025.
  • 416 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.